Study: Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes
16 Aug, 2018 | 23:09h | UTCSex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data – Diabetes Care (link to abstract – $ for full-text)
Commentary: Doctors should use gender and body mass to personalise diabetes care, study says – The Irish News (free)
Source: The BMJ Research News ($)